Literature DB >> 24994872

Androgen deficiency and dry eye syndrome in the aging male.

Patrick M Azcarate1, Vincent D Venincasa1, William Feuer2, Frank Stanczyk3, Andrew V Schally4, Anat Galor1.   

Abstract

PURPOSE: To evaluate the relationship between androgen levels and subjective and objective measures of dry eye syndrome (DES).
METHODS: A total of 263 male patients from the Miami Veterans Affairs Medical Center eye clinic aged ≥50 were recruited for this prospective cross-sectional study. Patients completed Dry Eye Questionnaire 5, underwent tear film evaluation, and had serum androgen levels measured. The correlations between androgen levels, DES composite scores, DES symptoms, and global, lipid, and aqueous tear film parameters were evaluated.
RESULTS: Two hundred sixty-three patients with a mean age of 69 (50-95) were examined. There was no linear association between composite DES scores (generated using latent class analysis) and androgen levels. However, eyes with high DES scores (0.95-1.0) had higher levels of sex hormone-binding globulin (P = 0.03) and lower levels of dehydroepiandrosterone sulfate (DHEAS) (P = 0.02), androstenedione (A) (P = 0.02), and androstane-3α,17β-diol glucuronide (P = 0.03) compared to eyes with intermediate (0.05-0.95) or low (0-0.05) scores. There were no strong correlations between tear film measures and androgen levels. Regarding global parameters, a weak inverse correlation was found between corneal staining and A (r = -0.17, P = 0.009). For lipid parameters, a weak correlation existed between tear breakup time (TBUT) and A (r = 0.15, P = 0.02). When considering aqueous and lipid deficiency independently, the association between TBUT and A existed only with aqueous tear deficiency (r = 0.66, P = 0.002). Regarding aqueous parameters, a weak correlation existed between Schirmer test and DHEAS (r = 0.13, P = 0.047) and A (r = 0.21, P = 0.001).
CONCLUSIONS: There was a weak correlation between higher levels of androstenedione and healthier global, lipid, and aqueous tear film parameters. Copyright 2014 The Association for Research in Vision and Ophthalmology, Inc.

Entities:  

Keywords:  androgens; dry eye syndrome; meibomian gland

Mesh:

Substances:

Year:  2014        PMID: 24994872      PMCID: PMC4132553          DOI: 10.1167/iovs.14-14689

Source DB:  PubMed          Journal:  Invest Ophthalmol Vis Sci        ISSN: 0146-0404            Impact factor:   4.799


  50 in total

1.  Androgen support of lacrimal gland function.

Authors:  A M Azzarolo; A K Mircheff; R L Kaswan; F Z Stanczyk; E Gentschein; L Becker; B Nassir; D W Warren
Journal:  Endocrine       Date:  1997-02       Impact factor: 3.633

2.  Androgen control of gene expression in the mouse meibomian gland.

Authors:  Frank Schirra; Tomo Suzuki; Stephen M Richards; Roderick V Jensen; Meng Liu; Michael J Lombardi; Patricia Rowley; Nathaniel S Treister; David A Sullivan
Journal:  Invest Ophthalmol Vis Sci       Date:  2005-10       Impact factor: 4.799

3.  Identification of androgen receptor protein and 5alpha-reductase mRNA in human ocular tissues.

Authors:  E M Rocha; L A Wickham; L A da Silveira; K L Krenzer; F S Yu; I Toda; B D Sullivan; D A Sullivan
Journal:  Br J Ophthalmol       Date:  2000-01       Impact factor: 4.638

Review 4.  DHEA and peripheral androgen and estrogen formation: intracinology.

Authors:  F Labrie; A Bélanger; J Simard; C Labrie
Journal:  Ann N Y Acad Sci       Date:  1995-12-29       Impact factor: 5.691

5.  Influence of aging on the polar and neutral lipid profiles in human meibomian gland secretions.

Authors:  Benjamin D Sullivan; James E Evans; M Reza Dana; David A Sullivan
Journal:  Arch Ophthalmol       Date:  2006-09

6.  The relative burden of dry eye in patients' lives: comparisons to a U.S. normative sample.

Authors:  Polyxane Mertzanis; Linda Abetz; Krithika Rajagopalan; Derek Espindle; Robin Chalmers; Christopher Snyder; Barbara Caffery; Timothy Edrington; Trefford Simpson; J Daniel Nelson; Carolyn Begley
Journal:  Invest Ophthalmol Vis Sci       Date:  2005-01       Impact factor: 4.799

7.  Improving awareness, identification, and management of meibomian gland dysfunction.

Authors:  Gary N Foulks; Kelly K Nichols; Anthony J Bron; Edward J Holland; Marguerite B McDonald; J Daniel Nelson
Journal:  Ophthalmology       Date:  2012-10       Impact factor: 12.079

8.  Meibomian gland dysfunction: a clinical scheme for description, diagnosis, classification, and grading.

Authors:  Gary N Foulks; Anthony J Bron
Journal:  Ocul Surf       Date:  2003-07       Impact factor: 5.033

9.  Low serum levels of sex steroids are associated with disease characteristics in primary Sjogren's syndrome; supplementation with dehydroepiandrosterone restores the concentrations.

Authors:  Helena Forsblad-d'Elia; Hans Carlsten; Fernand Labrie; Yrjö T Konttinen; Claes Ohlsson
Journal:  J Clin Endocrinol Metab       Date:  2009-03-24       Impact factor: 5.958

10.  Reproducibility of serum sex steroid assays in men by RIA and mass spectrometry.

Authors:  Ann W Hsing; Frank Z Stanczyk; Alain Bélanger; Paul Schroeder; Lilly Chang; Roni T Falk; Thomas R Fears
Journal:  Cancer Epidemiol Biomarkers Prev       Date:  2007-05       Impact factor: 4.254

View more
  15 in total

1.  Effect of mistletoe combined with carboxymethyl cellulose on dry eye in postmenopausal women.

Authors:  Nan Jiang; Lin-Hong Ye; Lei Ye; Jing Yu; Qi-Chen Yang; Qing Yuan; Pei-Wen Zhu; Yi Shao
Journal:  Int J Ophthalmol       Date:  2017-11-18       Impact factor: 1.779

2.  Efficacy of Several Therapeutic Agents in a Murine Model of Dry Eye Syndrome.

Authors:  Servet Kilic; Kadri Kulualp
Journal:  Comp Med       Date:  2016-04       Impact factor: 0.982

Review 3.  Androgen and meibomian gland dysfunction: from basic molecular biology to clinical applications.

Authors:  Li-Xiang Wang; Ying-Ping Deng
Journal:  Int J Ophthalmol       Date:  2021-06-18       Impact factor: 1.779

Review 4.  Effects of Aging in Dry Eye.

Authors:  Cintia S de Paiva
Journal:  Int Ophthalmol Clin       Date:  2017

5.  Frequency and risk factors associated with dry eye in patients attending a tertiary care ophthalmology center in Mexico City.

Authors:  Jaime D Martinez; Anat Galor; Nallely Ramos-Betancourt; Andrés Lisker-Cervantes; Francisco Beltrán; Jorge Ozorno-Zárate; Valeria Sánchez-Huerta; Marco-Antonio Torres-Vera; Everardo Hernández-Quintela
Journal:  Clin Ophthalmol       Date:  2016-07-21

6.  Morphology and Function of Meibomian Glands and Other Tear Film Parameters in Junior High School Students.

Authors:  Takanori Mizoguchi; Reiko Arita; Shima Fukuoka; Naoyuki Morishige
Journal:  Cornea       Date:  2017-08       Impact factor: 2.651

Review 7.  Aging: a predisposition to dry eyes.

Authors:  Anushree Sharma; Holly B Hindman
Journal:  J Ophthalmol       Date:  2014-08-14       Impact factor: 1.909

8.  Tear Film Steroid Profiling in Dry Eye Disease by Liquid Chromatography Tandem Mass Spectrometry.

Authors:  Damiana Pieragostino; Luca Agnifili; Ilaria Cicalini; Roberta Calienno; Mirco Zucchelli; Leonardo Mastropasqua; Paolo Sacchetta; Piero Del Boccio; Claudia Rossi
Journal:  Int J Mol Sci       Date:  2017-06-24       Impact factor: 5.923

9.  Histopathology and selective biomarker expression in human meibomian glands.

Authors:  Lixing W Reneker; Rebecca T Irlmeier; Ying-Bo Shui; Ying Liu; Andrew J W Huang
Journal:  Br J Ophthalmol       Date:  2019-10-04       Impact factor: 4.638

10.  An Eyelid Warming Device for the Management of Meibomian Gland Dysfunction.

Authors:  William Ngo; Sruthi Srinivasan; Lyndon Jones
Journal:  J Optom       Date:  2018-10-16
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.